Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “cd71”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Not applicableNot Yet RecruitingNCT05440747
What this trial is testing

Treatment Free Remission (TFR) in CML Patients （CML-CP）Study

Who this might be right for
Chronic Myeloid LeukemiaTreatment-free Remission
Guangdong Provincial People's Hospital 203
Post-approval studies (Phase 4)Study completedNCT07105319
What this trial is testing

Ropeginterferon for Treatment Free Remission

Who this might be right for
CML (Chronic Myelogenous Leukemia)
Dong-Wook Kim 65
Not applicableStudy completedNCT03801161
What this trial is testing

Influence of Inflammation on Micronutrient Status Assessment

Who this might be right for
Healthy Infants
International Centre for Diarrhoeal Disease Research, Bangladesh 75
Not applicableUnknownNCT03720977
What this trial is testing

Diagnostic Value and Biological Significant of cd71 in Lymphoid Disorders

Who this might be right for
Lyphoid Disorderscd71
Marwa Aboelim Shafeik 139
Not applicableStudy completedNCT03647124
What this trial is testing

Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Participants With Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Lymphoma, Mantle-Cell
Celgene 105
Large-scale testing (Phase 3)Study completedNCT01743989
What this trial is testing

Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.

Who this might be right for
Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
Novartis Pharmaceuticals 620
Testing effectiveness (Phase 2)Ended earlyNCT03874858
What this trial is testing

Full Treatment-free Remission in Patients With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 135
Large-scale testing (Phase 3)Active Not RecruitingNCT05456191
What this trial is testing

Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)

Who this might be right for
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
Novartis Pharmaceuticals 568
Large-scale testing (Phase 3)Ended earlyNCT05413915
What this trial is testing

Asciminib Used in Consolidation With Imatinib vs. Imatinib to Achieve TFR in CP-CML

Who this might be right for
Chronic Myeloid LeukemiaChronic Myeloid Leukemia, BCR/ABL-PositiveChronic Myeloid Leukemia in Remission
Sarit Assouline 8
Testing effectiveness (Phase 2)Looking for participantsNCT07738107
What this trial is testing

ATR 1072 in Participants With PRKAG2 Syndrome

Who this might be right for
Cardiac GlycogenosisCardiomyopathyHypertrophic+1 more
Atrium Therapeutics 37
Not applicableUnknownNCT05152537
What this trial is testing

FLOR3 Gene Polymorphism in Predicting Outcomes of Tyrosine Kinase Inhibitor（TKI）Stopping in Chronic Myeloid Leukemia

Who this might be right for
FolateCMLTreatment-free Remission
Affiliated Hospital of Nantong University 15
Early research (Phase 1)Study completedNCT00003082
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Arizona 27
Testing effectiveness (Phase 2)Study completedNCT03543813
What this trial is testing

PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL

Who this might be right for
Solid Tumor, AdultHead and Neck CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 133
Not applicableStudy completedNCT06668545
What this trial is testing

Investigating CD 71 in Preeclamptic Pregnancies

Who this might be right for
PreeclampsiaPlacenta Diseases
Manisa Celal Bayar University 39
Not applicableStudy completedNCT04621851
What this trial is testing

Retro-prospective Observational Study on Risk of Progression in CP-CML Patients Eligible for TKI Discontinuation

Who this might be right for
Chronic Myeloid Leukemia
University of Milano Bicocca 260
Testing effectiveness (Phase 2)Study completedNCT04346654
What this trial is testing

Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals 26
Very early researchStudy completedNCT04073849
What this trial is testing

CD71 in Dried Blood Spots in Healthy Males

Who this might be right for
Healthy Athletes
Sports Medicine Research and Testing Laboratory 24
Not applicableStudy completedNCT02481375
What this trial is testing

Is Iron Deficiency the Cause of Anemia Among Women in Cambodia?

Who this might be right for
AnemiaIron DeficiencyHemoglobin Disorder+2 more
University of British Columbia 809
Not applicableStudy completedNCT02957838
What this trial is testing

Mitochondrial Effects of C18:0 Supplementation in Humans

Who this might be right for
Alteration of Mitochondrial MembraneType2 DiabetesFatty Acid Deficiency
University Hospital Heidelberg 23
Post-approval studies (Phase 4)Not Yet RecruitingNCT07839988
What this trial is testing

De-escalation Strategy of Tyrosine Kinase Inhibitors Before Treatment Discontinuation in Patients With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia in Chronic Phase
Nanfang Hospital, Southern Medical University 280
Next Page